Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of rMenB and rMenB+OMV NZ Vaccine in Children
NCT01026974Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2010
- Primary completion
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Multicomponent meningococcal B vaccine in meningococcal disease, sponsored by Novartis. Started Feb 2010; status: completed.
02
Drugs
Multicomponent meningococcal B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01026974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01026974.